Natural History of Patients with Multiple Myeloma Refractory to Elotuzumab and Outcomes of Subsequent Therapy with Anti-CD38 Monoclonal Antibodies
Year: 2018
Type: conference-abstract
Source: Blood
Authors: William Varnado, Megan Helena Jagosky, Zhubin Gahvari, Saurabh Chhabra, Ujjawal H Gandhi, Arjun Lakshman, Elizabeth McGehee, Ridhi Gupta, Ehsan Malek, Mark A. Fiala, Joshua Mansour, Barry Paul, Alyssa Barnstead, Saranya Kodali, Neppalli Amarendra, Michaela Liedtke, Kelly N. Godby, Yubin Kang, Ankit Kansgra, Emma C. Scott, Elvira Umyarova, Parameswaran Hari, Ravi Vij, Saad Z. Usmani, Robert Frank Cornell, Shaji K. Kumar, Natalie Scott Callander, Luciano J Costa
Institutions: University of Alabama at Birmingham, Levine Cancer Institute, University of Wisconsin–Madison, Medical College of Wisconsin, Vanderbilt University, Vanderbilt University Medical Center, Mayo Clinic, The University of Texas Southwestern Medical Center, Stanford Cancer Institute, Stanford University, University of Cincinnati, Washington University in St. Louis, Medical University of South Carolina, Duke University, Duke Medical Center, Oregon Health & Science University, University of Vermont, Stanford Medicine, OHSU Knight Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907841473